Trial Profile
Effects of Sitagliptin on Postprandial Glycaemia, Incretin Hormones and Blood Pressure in Type 2 Diabetes - Relationship to Gastric Emptying
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetes mellitus; Gastroparesis
- Focus Therapeutic Use
- 05 Jul 2017 Status changed from recruiting to completed.
- 09 Oct 2016 Planned End Date changed from 1 Aug 2016 to 1 Nov 2016.
- 09 Oct 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Nov 2016.